Medical device manufacturer, Atricure Inc., will pay the United States $3.76 million to resolve claims of Medicare fraud and violations of the Food, Drug and Cosmetic Act.

Allegations included promoting its medical devices for uses which are not approved by the U.S. Food and Drug Administration. The West Chester, Ohio-based company was also accused of paying kickbacks and promoting unnecessary and expensive heart surgery using devices developed by the company.

The case began with a qui tam, or whistleblower, lawsuit by an unnamed private citizen, who will receive $625,000 from the total settlement.

Click here to read the full article, “Atricure to Pay U.S. $3.76 Million to Resolve Medicare Fraud Allegations”